Removal of Drugs for Alzheimer's Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA)

Removal of Drugs for Alzheimer's Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA). Herr, Marie; Ankri, Joël; Diard, Capucine; Hiance-Delahaye, Anne. Drugs & Aging. 2021; 38: p.63-74. doi:10.1007/s40266-020-00817-3
Article